IPO Valuation

Senator Elizabeth Warren has formally asked the SEC to delay SpaceX’s planned IPO, scheduled to begin Nasdaq trading as early as June 12 under ticker “SPCX,” citing structural disadvantages to retail investors and concerns over a $1.75 trillion valuation that Wall Street analysts say may be severely overpriced. The move exposes a critical tension for institutional investors: index fund rules requiring rapid inclusion of mega-cap debuts could lock them into purchasing an overvalued asset at artificially inflated prices, spreading concentration risk across millions of retirement accounts.

• SpaceX IPO targets 555 million Class A shares at $135 each, raising roughly $75 billion with a $1.75 trillion valuation.
• The company’s price-to-sales ratio of 103 is approximately 40 percent higher than Palantir, the current most expensive S&P 500 stock.
• Morningstar analyst Nicolas Owens values SpaceX at $780 billion, roughly half the IPO target price, expecting a post-debut buying opportunity.

• $1.75T Target valuation for SpaceX IPO, compared to Morningstar’s $780 billion fair value estimate
• 103x SpaceX price-to-sales ratio, versus 40 percent premium to most expensive S&P 500 stock
• June 12 Planned trading debut date on Nasdaq under ticker symbol SPCX

Senator Elizabeth Warren has escalated her scrutiny of financial markets by formally requesting that the Securities and Exchange Commission delay SpaceX’s initial public offering, scheduled to launch on the Nasdaq as early as June 12 under ticker “SPCX.” In a letter to SEC Chair Paul Atkins, Warren outlined specific concerns about the offering’s structure, arguing that the deal disadvantages retail investors and that the company’s $1.75 trillion target valuation lacks fundamental justification.

SpaceX plans to issue 555 million Class A shares priced at $135 each, an offering that would rank as the largest in U.S. history by capital raised at roughly $75 billion.

The timing of Warren’s intervention coincides with intensifying debate among Wall Street analysts over whether SpaceX can justify its asking price.

The company’s proposed valuation implies a price-to-sales ratio of approximately 103 times based on $19.3 billion in revenue over the last four quarters, a multiple roughly 40 percent steeper than Palantir Technologies, currently the most expensive stock in the S&P 500 by this metric. This valuation gap has become the focal point of institutional concern.

For index fund managers, the timing creates an immediate regulatory problem.

Warren Flags Structural Disadvantage to Retail Investors in SpaceX IPO Design

Warren’s letter identified a fundamental asymmetry in how the IPO is structured, with particular emphasis on how regular, non-professional investors would be positioned relative to institutional buyers.

The senator has built a reputation for intervening in high-stakes financial moments, having launched investigations into corporate compliance and regulatory oversight across banking, crypto, and technology sectors. Her formal objection to the SpaceX offering represents a deliberate attempt to force the SEC to examine whether the deal’s terms meet standards for investor protection.

The structural concerns Warren raised extend beyond valuation disagreement. She questioned whether the pricing mechanism and share allocation reflect fair market discovery or instead represent a predetermined outcome designed to benefit early investors and underwriters.

This critique aligns with broader institutional scrutiny of how mega-cap technology IPOs are priced in a market where demand from passive index funds may exceed genuine price-discovery mechanisms.

Warren’s intervention reflects her track record of scrutinizing major financial institutions and regulatory decisions. In May 2026, she launched investigations into the approval of national charters for crypto companies including Coinbase and Ripple, accusing federal agencies of allowing these firms to bypass traditional banking oversight rules.

Since January 2026, her office has tracked more than a dozen separate investigations targeting regulatory decisions across the Trump administration, including demands for records from the Treasury Department and the Office of the Comptroller of the Currency.

Morningstar Analyst Values SpaceX at Half the IPO Target, Predicting Post-Debut Price Decline

Institutional analysis of SpaceX’s valuation reveals a stark divide between the IPO price target and independent fundamental assessments. Morningstar analyst Nicolas Owens calculated SpaceX’s fair value at approximately $780 billion, roughly half the $1.75 trillion implied by the proposed share price.

Owens publicly stated he expects investors will have the opportunity to purchase SpaceX shares at substantially lower prices following the debut.

This valuation gap carries concrete implications for portfolio managers and index fund operators. If Owens’ assessment proves accurate, early buyers locking in shares at $135 would face immediate mark-to-market losses once secondary trading establishes a lower equilibrium price.

For passive investors in S&P 500 or broad market index funds, this dynamic creates forced purchasing pressure at inflated valuations with no opportunity to wait for more rational pricing.

The valuation disconnect also signals broader concerns about IPO pricing discipline in concentrated markets. SpaceX’s $19.3 billion in trailing twelve-month revenue, when divided into the $1.75 trillion target valuation, yields a price-to-sales multiple that has rarely appeared among large-cap equities.

For context, this multiple is 40 percent higher than Palantir Technologies, which currently holds the distinction of being the most expensive stock by this metric in the entire S&P 500 index.

Index Inclusion Rules May Force Fund Managers to Buy SpaceX Regardless of Valuation Concerns

A critical structural issue underlying Warren’s intervention involves recent changes to index composition rules that would require major stock indexes to rapidly add SpaceX following its IPO debut.

Under these rules, passive index funds tracking the S&P 500, Russell 2000, or other benchmarks would be forced to purchase SpaceX shares at whatever market price prevails at inclusion, regardless of whether that price exceeds fundamental value estimates.

This mandatory inclusion dynamic creates systemic risk concentration. If SpaceX enters the index at or near the $1.75 trillion valuation and subsequently experiences a significant price correction, millions of retirement savings accounts passively tracking these indexes would absorb the loss simultaneously.

The fund managers overseeing these accounts would have no discretion to avoid the purchase or to wait for better entry points, transforming what might be an individual stock risk into a broad market event affecting ordinary investors who hold index funds through employer retirement plans.

Warren’s intervention targets precisely this mechanism, attempting to force regulatory review before the inclusion rules force institutional buying pressure into an asset she and independent analysts consider overpriced.

The SEC’s response to Warren’s formal request will determine whether the June 12 launch date proceeds as planned or faces delay. Chair Paul Atkins now faces a decision between allowing market forces and index mechanics to proceed, or responding to Warren’s concerns by requesting additional disclosures, valuation justification, or structural modifications to the offering.

The political dimension of this decision matters: Warren’s office has maintained active investigation oversight of the Trump administration’s regulatory decisions across multiple agencies, giving her request considerable weight in the SEC’s calculus.

The central unresolved question is whether the SEC will grant Warren’s request for delay or allow the June 12 debut to proceed as planned. SEC Chair Paul Atkins’ decision on whether to request additional SpaceX disclosures or structural changes will directly determine whether index funds face forced purchasing at $1.75 trillion valuation or whether Morningstar’s $780 billion fair value estimate gets a chance to influence secondary market pricing before passive mandate purchases begin.